Efficient incorporation and protection of lansoprazole in cyclodextrin metal-organic frameworks.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Jul 2020
Historique:
received: 29 04 2020
revised: 14 05 2020
accepted: 15 05 2020
pubmed: 24 5 2020
medline: 4 3 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Lansoprazole (LPZ) is an acid pump inhibitor, which readily degrades upon acidic or basic conditions and under heating. We investigated here LPZ stability upon incorporation in particles made of cyclodextrin metal-organic frameworks (CD-MOFs). LPZ loaded CD-MOFs were successfully synthesized, reaching high LPZ payloads of 23.2 ± 2.1 wt%, which correspond to a molar ratio of 1:1 between LPZ and γ-CD. The homogeneity of LPZ loaded CD-MOFs in terms of component distribution was confirmed by elemental mapping by STEM-EDX. Both CTAB, the surfactant used in the CD-MOFs synthesis, and LPZ compete for their inclusion in the CD cavities. CTAB allowed obtaining regular cubic particles of around 5 µm with 15 wt% residual CTAB amounts. When LPZ was incorporated, the residual CTAB amount was less than 0.1 wt%, suggesting a higher affinity of LPZ for the CDs than CTAB. These findings were confirmed by molecular simulations. Vibrational circular dichroism studies confirmed the LPZ incorporation inside the CDs. Solid-state NMR showed that LPZ was located in the CDs and that it remained intact even after three years storage. Remarkably, the CD-MOFs matrix protected the drug upon thermal decomposition. This study highlights the interest of CD-MOFs for the incorporation and protection of LPZ.

Identifiants

pubmed: 32445910
pii: S0378-5173(20)30426-9
doi: 10.1016/j.ijpharm.2020.119442
pii:
doi:

Substances chimiques

Cyclodextrins 0
Drug Carriers 0
Metal-Organic Frameworks 0
gamma-Cyclodextrins 0
Lansoprazole 0K5C5T2QPG
Cetrimonium Z7FF1XKL7A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119442

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Xue Li (X)

Université Paris-Saclay, CNRS, Institut des Sciences Moléculaires d'Orsay, 91405 Orsay, France.

Marianna Porcino (M)

Université d'Orléans, CEMHTI UPR CNRS 3079, F-45071 Orléans, France.

Charlotte Martineau-Corcos (C)

Université d'Orléans, CEMHTI UPR CNRS 3079, F-45071 Orléans, France; Université Paris Saclay, ILV UMR CNRS 8180, Université de Versailles St-Quentin en Yvelines, 78035 Versailles, France; Institut Universitaire de France (IUF), 75005 Paris, France.

Tao Guo (T)

Center for Drug Delivery Systems, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201210 Shanghai, China.

Ting Xiong (T)

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, 330004 Nanchang, China.

Weifeng Zhu (W)

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, 330004 Nanchang, China.

Gilles Patriarche (G)

Université Paris-Saclay, CNRS, Centre de Nanosciences et de Nanotechnologies, 91120 Palaiseau, France.

Christine Péchoux (C)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350 Jouy-en-Josas, France.

Barbara Perronne (B)

Bruker Biospin Corporation, 8117 Fällanden, Switzerland.

Alia Hassan (A)

Bruker Biospin Corporation, 8117 Fällanden, Switzerland.

Rainer Kümmerle (R)

Bruker Biospin Corporation, 8117 Fällanden, Switzerland.

Alexandre Michelet (A)

PerkinElmer, 16 avenue du Québec, 91140 Villebon sur Yvette, France.

Anne Zehnacker-Rentien (A)

Université Paris-Saclay, CNRS, Institut des Sciences Moléculaires d'Orsay, 91405 Orsay, France.

Jiwen Zhang (J)

Center for Drug Delivery Systems, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201210 Shanghai, China; Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, 330004 Nanchang, China.

Ruxandra Gref (R)

Université Paris-Saclay, CNRS, Institut des Sciences Moléculaires d'Orsay, 91405 Orsay, France. Electronic address: ruxandra.gref@universite-paris-saclay.fr.

Articles similaires

Animals Dogs Dog Diseases Autophagy Immunohistochemistry
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH